Sensus Healthcare, Inc. (FRA:5TX)
Germany flag Germany · Delayed Price · Currency is EUR
4.260
+0.080 (1.91%)
At close: Jan 30, 2026

Sensus Healthcare Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
35.6141.8124.4144.5327.049.58
Revenue Growth (YoY)
-13.80%71.30%-45.20%64.68%182.36%-64.87%
Cost of Revenue
18.5317.3810.3514.910.054.33
Gross Profit
17.0824.4314.0629.6316.995.25
Selling, General & Admin
15.0512.1310.7611.349.439.33
Research & Development
7.464.223.683.463.444.16
Operating Expenses
22.5116.3414.4414.812.8713.48
Operating Income
-5.438.09-0.3814.834.12-8.23
Interest Expense
-----0-0.01
Interest & Investment Income
0.760.930.990.3800.07
EBT Excluding Unusual Items
-4.689.020.6115.214.12-8.18
Gain (Loss) on Sale of Assets
--0.0412.78-0-
Other Unusual Items
-----1.35
Pretax Income
-4.689.020.6527.994.12-6.84
Income Tax Expense
-1.672.380.173.75--
Net Income
-3.016.650.4924.244.12-6.84
Net Income to Common
-3.016.650.4924.244.12-6.84
Net Income Growth
-1270.51%-98.00%488.59%--
Shares Outstanding (Basic)
161616161616
Shares Outstanding (Diluted)
161616171716
Shares Change (YoY)
0.03%0.57%-2.12%0.70%0.42%1.24%
EPS (Basic)
-0.180.410.031.470.25-0.42
EPS (Diluted)
-0.180.410.031.460.25-0.42
EPS Growth
-1266.06%-97.96%484.00%--
Free Cash Flow
2.17-1.11-2.37-1.57-0.41-0.79
Free Cash Flow Per Share
0.13-0.07-0.15-0.10-0.03-0.05
Gross Margin
47.95%58.44%57.61%66.53%62.82%54.81%
Operating Margin
-15.26%19.35%-1.57%33.30%15.24%-85.98%
Profit Margin
-8.44%15.90%1.99%54.44%15.23%-71.38%
Free Cash Flow Margin
6.09%-2.65%-9.73%-3.53%-1.53%-8.28%
EBITDA
-5.078.33-0.1115.154.73-7.51
EBITDA Margin
-14.22%19.92%-0.44%34.01%17.50%-78.44%
D&A For EBITDA
0.370.240.280.320.610.72
EBIT
-5.438.09-0.3814.834.12-8.23
EBIT Margin
-15.26%19.35%-1.57%33.30%15.24%-85.98%
Effective Tax Rate
-26.32%25.61%13.38%--
Advertising Expenses
-1.21.20.90.460.52
Source: S&P Global Market Intelligence. Standard template. Financial Sources.